共 219 条
[1]
Martinsen TC(2005)Gastric juice: a barrier against infectious diseases Basic Clin Pharmacol Toxicol 96 94-102
[2]
Bergh K(2020)Evidence for gastrointestinal infection of SARS-CoV-2 Gastroenterology 158 1831-1833
[3]
Waldum HL(2021)Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor? J Intern Med 289 121-124
[4]
Xiao F(2020)Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters Nat Microbiol 5 1439-1448
[5]
Tang M(2020)Famotidine use is associated with improved clinical outcomes in hospitalized COVID–19 patients: a retrospective cohort study Gastroenterology 159 1129-1131
[6]
Zheng X(2021)Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID-19: a meta-analysis J Intern Med 289 125-128
[7]
Liu Y(2020)Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection Dig Liver Dis 52 1410-1412
[8]
Li X(2020)Effect of acid suppressants on the risk of COVID-19: a propensity score-matched study using UK Biobank Gastroenterology 160 455-458.e5
[9]
Shan H(2021)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews BMJ 372 516-524
[10]
Luxenburger H(1984)Reducing bias in observational studies using subclassification on the propensity score J Am Stat Assoc 79 1539-1558